Citadel Advisors
VSEEW

Citadel Advisors’s VSEE HEALTH INC WTS 29 VSEEW Stock Holding History

Citadel Advisors’s Portfolio VSEEW Stock Details VSEEW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$716 Sell
22,385
-3,115
-12% -$119 ﹤0.01% 13559
2026
Q1 		$944 Buy
25,500
+2,832
+12% +$162 ﹤0.01% 12839
2025
Q4 		$1.81K Buy
+22,668
New +$2.41K ﹤0.01% 12481
2025
Q1 		– Sell
-17,330
Closed -$763 – 15790
2024
Q4 		$763 Sell
17,330
-2,900
-14% -$154 ﹤0.01% 14273
2024
Q3 		$829 Sell
20,230
-1,598
-7% -$173 ﹤0.01% 13949
2024
Q2 		$4.37K Buy
+21,828
New +$3.29K ﹤0.01% 13493

Other funds holding VSEEW

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
QCIG
Quad-Cities Investment Group Davenport, Iowa $278M AUM 22.38% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Citadel Advisors's VSEEW Position: Q2 2026 in Review

Citadel Advisors reduced its VSEE HEALTH INC WTS 29 (VSEEW) stake by 12% in Q2 2026, selling an estimated $119 and leaving 22,385 shares worth $716. The position accounts for ﹤0.01% of the portfolio, ranked #13559.

Citadel Advisors first reported a position in VSEEW in Q2 2024 and has held it in 6 quarters since. The position peaked at $4.37K in Q2 2024. 19 funds tracked by Wall St. Rank hold VSEEW as of Q2 2026.

  • Citadel Advisors held 22,385 shares of VSEE HEALTH INC WTS 29 worth $716 as of Q2 2026.
  • Citadel Advisors sold 3,115 VSEE HEALTH INC WTS 29 shares in Q2 2026, an estimated $119.
  • VSEE HEALTH INC WTS 29 made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13559 holding.
  • Citadel Advisors first reported a position in VSEE HEALTH INC WTS 29 in Q2 2024 and has held it in 6 quarters since.
  • Citadel Advisors's VSEE HEALTH INC WTS 29 position peaked at $4.37K in Q2 2024.
  • 19 funds tracked by Wall St. Rank held VSEE HEALTH INC WTS 29 as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.